简体中文 | 繁體中文 | English

CONVIDIEN

Covidien plc to Report First-Quarter Results on January 20, 2010

2009-12-17 11:46
  • zh_cn
  • zh_hant
  • en

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report first-quarter results before trading begins on January 20, 2010. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

  • At Covidien’s website: http://investor.covidien.com
  • By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-510-0219. For participants outside the U.S., the dial-in number is 617-614-3451. The access code for all callers is 94242633.
  • Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on January 20, 2010, and ending at 5:00 p.m. on January 27, 2010. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 41226018.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue in excess of $10 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts

Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth@covidien.com